1 / 6

Rheumatoid Arthritis Drugs Market is Expected to Expand at a CAGR of 2.96% from 2018 to 2026

Global rheumatoid arthritis drugs market is expected to expand at a CAGR of 2.96% from 2018 to 2026. In 2016, the global market was valued at US$ 19597.43 Mn.

pharmahealth
Download Presentation

Rheumatoid Arthritis Drugs Market is Expected to Expand at a CAGR of 2.96% from 2018 to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ©2019 Transparency Market Research, All Rights Reserved Rheumatoid Arthritis Drugs Market Drug Type - Disease-modifying Anti-rheumatic Drugs (DMARDs), Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Response Modifiers (Biologics); Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy Forecast From 2018 - 2026 ©2019 Transparency Market Research, All Rights Reserved

  2. ©2019 Transparency Market Research, All Rights Reserved Table of Content Sr. No. Content Chapter 1 Preface Chapter 2 Assumptions and Research Methodology Chapter 3 Executive Summary Chapter 4 Market Overview Chapter 5 Market Outlook Chapter 6 Global Rheumatoid Arthritis Drugs Market Analysis, by Drug Type Chapter 7 Global Rheumatoid Arthritis Drugs Market Analysis, by Distribution Channel Chapter 8 Global Rheumatoid Arthritis Drugs Market Analysis, by Region Chapter 9 North America Rheumatoid Arthritis Drugs Market Analysis Chapter 10 Europe Rheumatoid Arthritis Drugs Market Analysis Chapter 11 Asia Pacific Rheumatoid Arthritis Drugs Market Analysis Chapter 12 Latin America Rheumatoid Arthritis Drugs Market Analysis Chapter 13 Middle East & Africa Rheumatoid Arthritis Drugs Market Analysis Chapter 14 Competitive Landscape

  3. ©2019 Transparency Market Research, All Rights Reserved Snapshot: • Rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints. In this disease, the immune system mistakenly affects the joints, causing inflammation and pain in the joints throughout the body. Rise in geriatric population, high prevalence of rheumatoid arthritis, and increase in patient preference for biological origin drugs are major drivers of the global rheumatoid arthritis drugs market. • • global rheumatoid arthritis drugs market can be segmented based on drug type, distribution channel, and geography. ©2019 Transparency Market Research, All Rights Reserved

  4. ©2019 Transparency Market Research, All Rights Reserved

  5. ©2019 Transparency Market Research, All Rights Reserved Reports Highlights Global rheumatoid arthritis drugs market is expected to expand at a CAGR of 2.96% from 2018 to 2026. In 2016, the global market was valued at US$ 19597.43 Mn. • • Key Players – Pfizer, Inc., Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol-Myers Squibb Company, and Eli Lilly and Company. ©2019 Transparency Market Research, All Rights Reserved Request Sample

  6. ©2019 Transparency Market Research, All Rights Reserved To know more about us, please visit our website: www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com For other queries contact: 90 State Street, Albany NY – 12207, United States Tel: +1-518-618-1030 T H A N K Y O U

More Related